Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Saad

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Blood Advances|September 23, 2022
Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AMLAarif M N Batcha, Nele Buckup, Stefanos A Bamopoulos, et al.
Blood|December 12, 2022
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemiaHeikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela, et al.
Leukemia|April 9, 2025
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genesFadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Blood Advances|September 23, 2022
Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AMLAarif M N Batcha, Nele Buckup, Stefanos A Bamopoulos, et al.
Blood|December 12, 2022
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemiaHeikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela, et al.
Leukemia|April 9, 2025
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genesFadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen, et al.
Pageof 2